To view this email as a web page, click here.

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

MULTIPLE SCLEROSIS

MS drugs make major advancements

By Christine Blank
Data on Gilenya presented at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Barcelona showed positive signs for patients with multiple sclerosis. Learn more

5 things you need to know about biosimilars

by Juliana Reed
After the first approval of biosimilars by the FDA this spring, the Biosimilars Forum offers 5 things all pharmacists should know to prepare for this new therapy. 5 things to know

CONTINUING EDUCATION

October 2015
MTM essentials for cold, flu, and sinusitis management

Session code: 15DT35-PTK48
This month’s CE activity is part of the CPE series, "Medication Therapy Management for the Patient with Respiratory Disease." From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to compare and contrast the common cold, influenza, and sinusitis, and discuss the role of the pharmacist as the medication expert for various treatment options and as a source to triage patients when needed.

To read and print the article with TEST QUESTIONS, click here.

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 15DT35-PTK48.
Copy the session code — 15DT35-PTK48 — before logging into the Online CE Center. When the page for the Online CE Center opens, paste the session code into the appropriate field, under your NABP ID.

EDITOR'S PICK

How Express Scripts will manage pricey cholesterol drugs

by Christine Blank
Express Scripts announced that it will include Praluent and Repatha in its National Preferred Formulary. This is a step forward for the price management of these cholesterol drugs. Read more here

October 21, 2015

Advertisement

Related Articles

MS drug linked to rare brain infection

[BLOG:] 5 reasons biosimilars must have distinguishable names

Resources

Get the latest FormularyWatch updates on drug approvals, current studies, and other findings.

Click for the latest Clinical News

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters